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Abstract
Nitric oxide (NO) plays an important role in the pathogenesis of neuronal injury during cerebral ischemia. The endothelial
and neuronal isoforms of nitric oxide synthase (eNOS, nNOS) generate NO, but NO generation from these two isoforms can
have opposing roles in the process of ischemic injury. While increased NO production from nNOS in neurons can cause
neuronal injury, endothelial NO production from eNOS can decrease ischemic injury by inducing vasodilation. However, the
relative magnitude and time course of NO generation from each isoform during cerebral ischemia has not been previously
determined. Therefore, electron paramagnetic resonance spectroscopy was applied to directly detect NO in the brain of mice
in the basal state and following global cerebral ischemia induced by cardiac arrest. The relative amount of NO derived from
eNOS and nNOS was accessed using transgenic eNOS(3/3) or nNOS(3/3) mice and matched wild-type control mice. NO
was trapped using Fe(II)^diethyldithiocarbamate. In wild-type mice, only small NO signals were seen prior to ischemia, but
after 10 to 20 min of ischemia the signals increased more than 4-fold. This NO generation was inhibited more than 70% by
NOS inhibition. In either nNOS(3/3) or eNOS(3/3) mice before ischemia, NO generation was decreased about 50%
compared to that in wild-type mice. Following the onset of ischemia a rapid increase in NO occurred in nNOS(3/3) mice
peaking after only 10 min. The production of NO in the eNOS(3/3) mice paralleled that in the wild type with a progressive
increase over 20 min, suggesting progressive accumulation of NO from nNOS following the onset of ischemia. NOS activity
measurements demonstrated that eNOS(3/3) and nNOS(3/3) brains had 90% and 6 10%, respectively, of the activity
measured in wild type. Thus, while eNOS contributes only a fraction of total brain NOS activity, during the early minutes of
cerebral ischemia prominent NO generation from this isoform occurs, confirming its importance in modulating the process of
ischemic injury. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Nitric oxide (NO) is produced under both physio-
logical and pathophysiological conditions by the en-
zyme nitric oxide synthase (NOS) which catalyzes the
conversion of L-arginine to L-citrulline and NO [1,2].
In the brain, there are two major isoforms of NOS,
the neuronal isoform (nNOS) present in neurons and
the endothelial isoform (eNOS) present primarily
within the vascular endothelium [3,4]. Previous stud-
ies have reported that alterations in NO generation
are of critical importance in the pathogenesis of cel-
lular injury during cerebral ischemia as occurs during
stroke or following cardiac arrest [5,6]. It has been
demonstrated that NO generation is greatly increased
during ischemia [6^9]. Direct trapping and measure-
ment of NO by electron paramagnetic resonance
(EPR) techniques [10,11] have shown that NO gen-
eration is greatly increased in the ischemic rat brain
[8,9]. The magnitude of this process was su⁄ciently
large to enable EPR imaging of the spatial localiza-
tion of NO formation in the rat brain [12]. However,
the alterations in NO and the function of NOS are
complex and can either induce injury or exert pro-
tection [13].
In vitro studies suggest that overproduction of NO
results in neuronal toxicity, while in vivo studies sug-
gest that NO has both protective and toxic e¡ects
[13,14]. It is thought that NO derived from nNOS
in the ischemic brain is cytotoxic due to its reaction
with the superoxide radical with the formation of the
potent oxidant peroxynitrite [15]. However, it is
thought that NO generated from eNOS within the
vascular endothelium may be protective through in-
ducing vasodilation which in turn decreases the
severity of ischemia. Studies in transgenic mice
have demonstrated that knockout out of nNOS
results in decreased infarct size in models of focal
cerebral ischemia. Conversely, studies in mice with
knockout of eNOS have shown exacerbation of in-
jury with increased infarct size. While these studies
suggest important opposing roles of NO generation
from each isoform, the relative magnitude and time
course of NO generation from nNOS and eNOS in
the ischemic brain have not been previously deter-
mined. Thus, there has been a need to characterize
the process of NO formation from each isoform in
cerebral ischemia.
Over the past decade, techniques have been devel-
oped for direct trapping and detection of NO in the
brain and other organs of rats using EPR spectros-
copy [8^11,16^19]. These techniques have been ap-
plied to measure and image NO generation in rat
brain following global cerebral ischemia. However,
similar measurements of NO in the ischemic mouse
brain have not been previously performed. To char-
acterize the roles of eNOS and nNOS in the process
of NO generation during the normal baseline state
and following cerebral ischemia, direct EPR trapping
and measurement of NO was performed to determine
the magnitude and time course of NO generation in
normal and transgenic mice with altered nNOS and
eNOS expression.
2. Materials and methods
2.1. Animals and chemical reagents
Transgenic homozygous eNOS knockout,
eNOS(3/3), and homozygous nNOS knockout,
nNOS(3/3), mice were used. Each of these trans-
genic mice have been extensively characterized in pri-
or studies. Southern blot analysis, Northern blot
analysis and Western blot analysis con¢rm the ab-
sence of DNA, mRNA and protein expression for
eNOS in the eNOS(3/3) mice and nNOS in the
nNOS (3/3) mice [20,21]. This has also been con-
¢rmed by immunohistology studies in the brain,
while brain cytoarchitecture and microvasculature
are normal [22]. The nNOS(3/3) mice were available
from the colony at Johns Hopkins maintained by Dr.
Valina Dawson and the eNOS(3/3) mice were from
a colony established at Johns Hopkins using breed-
ing pairs provided by Dr. Paul Huang. The wild-type
C57black/6 and SV129 mice used were purchased
from Charles River and Taconic, respectively.
Chemicals and reagents were purchased from Sig-
ma, unless otherwise noted. L-[14C]arginine was ob-
tained from DuPont NEN. DETC was from Aldrich
Chemical and protein assay reagents were from Bio-
Rad.
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2.2. Cerebral ischemia models
Cerebral ischemia was induced by cardiac arrest.
Mice were anesthetized with sodium pentobarbital
(50 mg/kg) by intraperitoneal injection, then thora-
cotomy was performed with cardiac arrest induced
by cross-clamp of the great vessels, aorta and pulmo-
nary artery, by clip [23]. The body temperature was
maintained at 37‡C by placement in an enclosed in-
cubator.
In a subgroup of animals, to simultaneously detect
NO in the brain and intracerebral blood, cerebral
ischemia was induced by bilateral ligation of the
common carotid artery. Mice were anesthetized
with pentobarbital (i.p., 40 mg/kg). Body tempera-
ture was maintained at 37‡C with a heating lamp.
After a ventral midline cervical incision, the common
carotid arteries were exposed and clipped for 20 min
of global ischemia [24]. The blood from a carotid
artery was sampled, and transferred to a 4-mm diam-
eter EPR tube and immediately frozen at liquid ni-
trogen temperature until EPR measurement was
performed. The brain was simultaneously removed
and prepared for EPR measurements as described
below.
2.3. EPR detection of nitric oxide
All reagents were dissolved in 0.9% NaCl solution.
DETC (400 mg/kg) and Fe-Citrate (40 mg FeSO4^
200 mg sodium citrate/kg) were injected intraperito-
neally and subcutaneously, respectively, 30 min prior
to the onset of cardiac arrest. At given times of
10 min, 20 min, 30 min, and 60 min after the onset
of cardiac arrest, the whole brain was rapidly dis-
sected, placed in a 3-ml plastic syringe, then extruded
though a 20-gauge needle and plastic tube into a
4-mm diameter EPR tube. Specimens were immedi-
ately frozen at liquid nitrogen temperature. The wild-
type animals received similar treatment but no vas-
cular cross-clamp or cerebral ischemia. In some ani-
mals, L-NAME (50 mg/kg) was injected intraperito-
neally 5 min before cardiac arrest to con¢rm that the
NO was derived from NOS.
EPR spectra were measured by X-Band, (W9.3
GHz) using a Bruker 300 spectrometer with liquid-
nitrogen ¢nger dewar placed in a TM110 cavity. Spec-
tra were recorded using 20 mW microwave power
with 100 kHz modulation. Relative quantitation of
the NO^Fe^DETC complex was performed from
measurement of the amplitude and intensity of the
observed triplet EPR spectra, as previously described
[25].
2.4. NOS activity assay
Brains were immediately frozen in liquid nitrogen,
¢nely ground and suspended in 3 ml of ice-cold bu¡-
er consisting of 50 mM Tris (pH 7.4), containing
0.1 mM EDTA, 0.1 mM EGTA, 12 mM mercapto-
ethanol, and 4 WM leupeptin. The suspension was
homogenized, and NOS activity measured by the
conversion of L-[14C]arginine to L-[14C]citrulline in
brain [3]. The reaction mixture contained 0.5 mM
NADPH, 500 WM CaCl2, 30 WM EDTA, 100 nM
calmodulin and 3 WM tetrahydrobiopterin in Tris
bu¡er. The reaction was initiated by the addition
of puri¢ed L-[14C]arginine at 10 WM ¢nal concentra-
tion and carried out for 8 min at 37‡C. The assay
incubation time was limited to 8 min to maximize
linearity and limit NO-mediated feedback inhibition
[26]. The reaction was quenched with 3 ml of ice-cold
stop bu¡er (20 mM Hepes and 2 mM EDTA, pH
5.5). Experiments were also performed in the pres-
ence of either L-NAME (500 WM). L-[14C]Citrulline
content was determined by liquid scintillation count-
ing after separation from the reaction mixture by
passage through a column of the cation exchange
resin Dowex AG 50WX-8 (500 Wl of the Na
form). Samples of bu¡er containing L-[14C]arginine
in the absence of brain tissue were added to the
Dowex resin column to determine background
counts, which were subtracted from all other meas-
urements. NOS activity was expressed as production
of pmol [14C]citrulline per mg protein per min. Total
protein was measured by the Bradford method.
2.5. Statistical analysis
All values are expressed as mean þ S.E.M., and
statistical signi¢cance of di¡erence was evaluated
by ANOVA with repeated measures and Fisher’s
post-hoc test. A P value of 0.05 or less was consid-
ered to indicate statistical signi¢cance.
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3. Results
3.1. Measurement of NO in the brain of wild-type
mice
While Fe(II)^DETC is EPR silent, following the
binding of NO a characteristic triplet EPR spectrum
is observed with a central g value of 2.04 and hyper-
¢ne splitting aN = 12.5 G [8^11]. In addition to this
signal, in biological tissues the spectrum of a Cu(II)^
DETC complex is also often observed. Measure-
ments of NO were performed in wild-type
C57black/6 nonischemic mice or mice subjected to
periods of global brain ischemia induced by cardiac
arrest. In control brain tissue, a small triplet signal of
the NO^Fe^DETC complex was seen centered at
g = 2.04 (3215^3275 G) as well as a larger peak at
high ¢eld of the Cu(II)^DETC complex (Fig. 1A). In
the brain tissue subjected to ischemia, a marked in-
crease in the NO triplet signal was seen while the
Cu(II) signal conversely decreased (Fig. 1B). In a
series of 7 mice subjected to 20 min of cerebral is-
chemia, a 4.0-fold increase was seen (P6 0.01).
SV129 wild-type mice after 20 min of cerebral ische-
mia also exhibited a similar 4-fold increase in brain
NO generation compared to levels in nonischemic
controls. A series of C57 wild-type mice were studied
with variable periods of cerebral ischemia ranging
from 10 to 60 min. After 10 min ischemia about a
3-fold increase in the NO signal was seen, while after
20 min a 4-fold increase was seen, which was then
followed by a progressive decline after 30 and 60 min
(Fig. 2). The increase observed was thus maximum
after 20 min of ischemia. To determine if the ob-
served NO signal was derived from the enzyme nitric
oxide synthase (NOS), studies were performed in
mice that were pretreated with the NOS inhibitor
L-NAME, 50 mg/kg, injected 5 min before the onset
of cardiac arrest. As shown in Fig. 3, L-NAME in-
hibited the increase of the NO signal by more than
70% in brains subjected to 20 min of ischemia follow-
ing cardiac arrest (P6 0.01). In repeat measurements
with and without L-NAME pretreatment (n = 4/
group), it was observed that L-NAME largely abol-
Fig. 1. EPR spectra of NO formation in the mouse brain. The
NO trap Fe^DETC was administered 30 min before the control
measurement or the onset of ischemia to wild-type mice. (A)
Nonischemic control ; (B) 10 min after the onset of cerebral
ischemia induced by cardiac arrest. EPR spectra were recorded
at a temperature of 77 K and microwave frequency of 9.29
GHz using 20 mW microwave power, 3.2 G modulation ampli-
tude with 100 kHz modulation frequency. b, NO^Fe^DETC
signal; a, Cu^DETC signal.
Fig. 2. EPR spectra of NO formation in mouse brain as a func-
tion of ischemic time. Measurements were performed on the
brains of wild-type mice as described in Fig. 1. The observed
NO signal reached a maximum at 20 min of ischemia.
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ished the increase in NO generation seen following
ischemia (Fig. 3).
3.2. Detection of NO in brain tissue and intracerebral
blood
Experiments were performed to determine if the
observed NO^Fe^DETC complex was located pri-
marily within the brain tissue or the intracerebral
blood pool. In mice subjected to cardiac arrest
when blood was allowed to drain from the intracere-
bral circulation and the brain was washed with
Krebs bu¡er, the observed signal was similar to
that seen when brains were rapidly frozen without
e¡ort to remove the intracerebral blood pool. To
further determine the proportion of the signal arising
from trapping in the intracerebral blood pool, experi-
ments were also performed in a model of global isch-
emia with bilateral occlusion of the common car-
otids. After 20 min of global ischemia, intracerebral
blood was drained from a carotid artery and the
brain tissue was then removed and frozen. As shown
in Fig. 4, the magnitude of the signal observed from
Fig. 3. E¡ect of NOS inhibition on NO generation in the ischemic mouse brain. Left panel: spectrum obtained after (A) 20 min isch-
emia; (B) 20 min ischemia in a mouse pretreated with the NOS inhibitor L-NAME, 50 mg/kg, injected intraperitoneally 5 min before
the onset of cerebral ischemia. Spectra were recorded as described in Fig. 1. Right panel: Bar graph showing the mean þ S.E.M. ob-
tained from nonischemic control brain, 20 min ischemic brain, and 20 min ischemic brain from animals pretreated with L-NAME,
four animals in each group. *P6 0.01 versus control. Inhibition of NOS with L-NAME decreased the NO generation by more than
70%.
Fig. 4. EPR measurement of NO trapping in the brains and in-
tracerebral blood. Mice were subjected to 20 min global isch-
emia by occlusion of both common carotid arteries and pre-
loaded with Fe^DETC 30 min before the onset of ischemia.
(A) Spectrum from brain; (B) spectra from blood. Spectra were
recorded as described in Fig. 1.
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the brain tissue was similar to that seen with cardiac
arrest induced ischemia, with a prominent NO triplet
signal seen. However, only a trace signal was present
in the intracerebral blood with signal intensity 10-
fold less than that in the brain. These studies indicate
that most of the observed NO signal detected in the
ischemic brain was from NO^Fe^DETC complexes
within the brain rather than the intracerebral blood
pool.
3.3. Measurement of NO generation in the transgenic
mice
Experiments were performed measuring NO gen-
eration in eNOS(3/3) and nNOS(3/3) mice sub-
jected to the cardiac arrest model of global cerebral
ischemia, as described above for the wild-type mice.
A series of eNOS(3/3), nNOS(3/3), and wild-type
mice were subjected to either no cerebral ischemia or
periods of cerebral ischemia of 10, 20, 30, or 60 min.
At least three mice were studied in each group for
each time point. EPR spectra of the NO^Fe^DETC
signal were recorded in each of these brains. In both
preischemic measurements and following 20 min of
ischemia the magnitude of the NO signals was de-
creased about 2-fold in both the eNOS(3/3) and the
nNOS(3/3) brains compared to the levels seen in
wild-type brains (Fig. 5). In both knockouts, the lev-
els of NO detected were signi¢cantly less than those
in the wild type (P6 0.01). The time course of NO
generation in the eNOS(3/3) brains mirrored that of
the wild type with 2.5-fold increase after 10 min
ischemia and a 4-fold increase to a maximum value
after 20 min ischemia followed by a subsequent de-
Fig. 5. EPR measurement of NO in wild-type (WT), eNOS(3/3) and nNOS(3/3) brain, prior to and following ischemia. Left panel:
prior to ischemia. Right panel : after 20 min global ischemia.
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cline (Fig. 6). The nNOS(3/3) showed a somewhat
di¡erent time course with maximum after only
10 min followed by a plateau and decline following
30 min. Thus, both eNOS and nNOS isoforms con-
tribute to the process of increased NO generation
during cerebral ischemia.
3.4. Measurement of NOS activity in the brain
While nNOS is known to be the major isoform of
NOS in the brain, eNOS is also present in the vas-
cular endothelium and has important functions in
regulating intracerebral £ow. In view of the measure-
ments of NO which demonstrated that prominent
NO generation persists in nNOS(3/3) brain, experi-
ments were performed to measure NOS activity in
the brain of both wild type and nNOS and eNOS
knockout mice. As shown in Fig. 7, the total brain
NOS activity in eNOS knockouts was 10% below
that in wild-type mice, while in nNOS knockouts
more than a 90% decrease in total brain NOS activ-
ity was seen. Thus, while eNOS contributes only a
small fraction of the total NOS activity measured in
brain homogenates under optimized conditions of
substrates and cofactors, it contributes a dispropor-
tionately high amount of the NO detected following
cerebral ischemia. The increased formation of NO by
eNOS in the vascular endothelium may represent a
protective mechanism of vasodilation following the
induction of ischemia.
Fig. 6. Graph of the time course of NO generation following ischemia in wild-type, eNOS(3/3) and nNOS(3/3) mouse brain. Data
were obtained from EPR measurements performed as described in Fig. 1. Data are expressed as the mean þ S.E.M. Three to six ani-
mals were studied at each time point. *P6 0.05, **P6 0.01 versus wild type.
Fig. 7. Measurement of total NOS activity in the brain of wild-
type, eNOS(3/3) and nNOS(3/3) mice. NOS activity was as-
sayed using the L-[14C]arginine to L-[14C]citrulline conversion as-
say in whole-brain homogenates. Data were expressed as the
mean þ S.E.M. obtained from three mice in each group.
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4. Discussion
The gaseous free radical nitric oxide, NO, is gen-
erated in biological tissues and is an important reg-
ulator of a broad range of functions [27]. It was ¢rst
shown that acetylcholine-induced vascular relaxation
is mediated by a labile factor termed endothelial de-
rived relaxing factor [28]. Subsequently, this factor
was shown to be NO [29^31]. NO synthesis was ¢rst
discovered in macrophages, endothelial cells, and
neuronal cells [30^32]. An enzyme was identi¢ed, ni-
tric oxide synthase (NOS), which synthesizes NO
from arginine, and three distinct isoforms were iden-
ti¢ed: nNOS in neurons, iNOS in macrophages, and
eNOS in endothelial cells [33,34]. eNOS is known to
regulate vascular tone, while nNOS is involved in
neural signaling, and iNOS modulates immune func-
tion [35^37]. NO exerts its functional e¡ects in cells
via binding and activation of speci¢c heme proteins
such as guanylate cyclase, however, larger amounts
can cause injury either due to direct binding to other
metalloproteins or via reaction with superoxide to
form the potent oxidant peroxynitrite [38].
Since NO is paramagnetic and binds with high
a⁄nity to a variety of metal chelates and metallopro-
teins, the distinctive electron paramagnetic reso-
nance, EPR, spectra of these nitrosyl complexes
can serve as a quantitative measure of NO genera-
tion [39,40]. The ferrous iron complex of DETC,
Fe(II)^DETC2 (Fe^DETC), has been widely applied
to measure NO in living tissues [8^11,41^43]. This
technique has been applied by several groups to
measure NO generation in the brain of rats [8^
10,43]. More recently, this technique was extended
along with EPR imaging instrumentation to spatially
map NO generation in the brain [12,44]. In the
present study, this NO trap was applied to measure
NO generation in the ischemic mouse brain in order
to access the role of nNOS and eNOS in the process
of the NO generation that occurs.
In recent years, it has become increasingly clear
that NO has a critical but complex role in the path-
ophysiology of cerebral ischemia. While it is clear
that NO is increased during cerebral ischemia and
reperfusion, it has been observed that this can have
di¡ering e¡ects in di¡erent models [45]. Therefore,
numerous studies have been performed to clarify
the functional role of NO in cerebral ischemic injury.
The majority of these have been based on the use of
NOS inhibitors, such as L-NAME, with measurement
of cerebral infarction in rodent models of focal
ischemia. The results of these studies have been com-
plex and contradictory in some cases, and it has been
observed that NO can mediate either protection or
injury in cerebral ischemia [13]. It has been suggested
that this variable e¡ect of NO in cerebral ischemia
may be due to the amount of NO [46], the time
course of NO production [47], the isoform or cellular
location of NOS as well as the redox state of NO or
NO derived species [48]. Studies using NO donors
demonstrated that in the early stages following focal
cerebral ischemia (6 2 h) the vascular actions of NO
are bene¢cial in promoting collateral circulation and
microvascular £ow [45,47]. It was also observed that
glutamate-induced Ca2 overload in ischemic neu-
rons leads to persistent activation of nNOS resulting
in continuous NO production [49]. It was suggested
that large amounts of NO produced by nNOS con-
tribute to metabolic deterioration of the penumbra,
the nonlethally injured ischemic border zone, result-
ing in more neuronal death with larger infarcts. It
was also reported from in vitro studies with cultured
primary neurons in the presence of NMDA or NO
donors that overproduction of NO is deleterious and
can result in neuronal injury [50]. It was reported in
NMDA-activated or ischemic neurons that NO and
superoxide generation result in the formation of the
potent oxidant peroxynitrite that can cause cellular
injury and death [15].
To explore the functional role of NO generated
from the two major constitutive NOS isoforms in
the brain, studies of focal cerebral ischemia were
previously performed in mice with knockout of either
nNOS or eNOS. It was observed that mice with
knockout of nNOS had smaller infarcts than wild-
type mice, suggesting that NO production from
nNOS in neurons was a critical mediator of neuronal
injury [22]. It was also reported that cultured neu-
rons from nNOS(3/3) mice were resistant to gluta-
mate-mediated toxicity and injury [51]. In mice with
knockout of eNOS it was observed, however, that
larger infarcts occurred than in wild-type mice, indi-
cating that endothelial production of NO was pro-
tective in this model of cerebral ischemia [52]. While
these physiological studies have suggested important
contrasting roles of NO derived from eNOS and
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nNOS in the pathogenesis of ischemic brain injury,
the process of NO formation from each isoform was
not previously characterized.
Therefore, in the present study we applied an EPR
spin-trapping method to measure NO in the brain of
wild-type or transgenic mice subjected to global is-
chemia. This method was adapted from the approach
previously used to measure NO in the brain of rats
with the coordinate complex Fe^DETC [8,9]. In ex-
periments measuring NO generation in the brain tis-
sue and in intracerebral blood, we demonstrated that
the NO^Fe^DETC was present in the brain tissue
rather than the intracerebral blood. It was observed
in wild-type mice that prominent NO generation oc-
curs following the onset of ischemia as evidenced by
the formation of the characteristic triplet EPR spec-
trum of the NO^Fe^DETC complex. A large 3-fold
increase in NO was seen after only 10 min, with a
4-fold increase after 20 min. Interestingly, after
20 min the NO signal declined, suggesting a com-
bination of decreased production or reaction with
other metalloproteins that could compete and scav-
enge NO preventing the formation of the NO^Fe^
DETC complex. A decrease in production could be
either a result of substrate limitation or loss of NOS
catalytic activity. It is possible that with lethal neuro-
nal injury with loss of integrity of the blood brain
barrier that the leak of hemoglobin into the brain
could be the source of a potent competitive scavenger
of NO. More than 70% of the NO generation
detected was blocked by inhibition of NOS with
L-NAME, indicating that this NO generation is de-
rived from the NOS-mediated conversion of L-argi-
nine to NO.
With knockout of nNOS or eNOS, lower baseline
preischemic levels of NO were seen. With either
knockout about a 50% decrease was seen, suggesting
that in the baseline state that a similar low level of
production and trapping of NO occurs from each
isoform. Following the onset of ischemia a rapid in-
crease in NO is seen in the nNOS(3/3) mice to a
peak after only 10 min. This suggests that eNOS-
mediated NO generation is stimulated early, in a
compensatory mechanism that would normally serve
to trigger vascular dilation. The production of NO in
the eNOS(3/3) mice paralleled that seen in the wild
type with a progressive increase over 20 min followed
by a gradual decline, suggesting that there is a pro-
gressive activation of and accumulation of NO from
nNOS following the onset of ischemia. In these stud-
ies it was observed that the total magnitude of NO
generation with either knockout was similar suggest-
ing that a large portion, almost half of the NO gen-
erated and trapped, is derived from eNOS. In a sep-
arate series of studies, we demonstrated in brain
homogenates from these mice that nNOS contributes
most of the activity of NOS in the normal wild-type
brain. From the eNOS(3/3) mice, it was seen that
with loss of eNOS only about a 10% loss of total
NOS activity occurs and from the nNOS(3/3)
mice, it was observed that nNOS contributes more
than 90^95% of the activity of the wild type. In spite
of this, the measurements of NO generation in the
intact ischemic brain demonstrated that eNOS con-
tributed a large portion of the NO generated follow-
ing the onset of cerebral ischemia. Thus, in spite of
the lower levels of enzyme expression and activity of
eNOS compared to nNOS in the brain, eNOS has a
prominent role in the generation of NO that occurs
following the onset of ischemia. This may be the
basis by which eNOS mediates vasodilation and lim-
its ischemic damage in models of focal ischemia.
The di¡erence between ex vivo NOS activity in
brain homogenates and NO production in the brain
before and following ischemia could be due to sev-
eral important factors. First, for the in vitro NOS
activity assay, optimum saturating amounts of sub-
strates and cofactors are present, while in the brain
substrates and cofactors can be limiting with variable
levels present in neurons and endothelial cells. Neu-
rons in the brain could lack critical substrates such as
L-arginine or cofactors such as tetrahydrobiopterin,
especially during cerebral ischemia, and this could in
turn limit NO generation from nNOS in the brain.
eNOS within the vascular endothelium, however,
would be expected to be less subject to substrate or
cofactor limitation. Limitation of these important
substrates and cofactors would not only limit NO
generation but also would result in a switch of
NOS from production of NO to superoxide that
would scavenge NO [53^55]. Second, in the brain, a
regulatory protein inhibitor of nNOS, PIN, has re-
cently been identi¢ed and this or other regulatory
proteins could also be contributing factors to limiting
NO generation from nNOS in the brain [56]. Finally
and perhaps most importantly, the process of calci-
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um-dependent activation could be quite di¡erent in
situ at vascular and neuronal sites.
Thus, in conclusion we observe that both neuronal
and endothelial isoforms of NOS have important
roles in the production of NO following the onset
of cerebral ischemia. This localized isoform speci¢c
production of NO at endothelial and neuronal sites
would be expected to exert important regulatory
roles in vascular and neuronal function and injury.
In diseases with cerebral ischemia, including stroke
and brain injury following cardiac arrest, the produc-
tion of NO from each of these NOS isoforms would
be particularly important. While NO generation
from eNOS would initially limit injury by inducing
vasodilation, subsequent nNOS mediated NO gener-
ation with accumulation of increasing amounts of
NO in the neurons of the brain would trigger cellular
injury.
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